Pharmaceutical Cold Chain Storage: How to Safeguard Medicines in 2025
Atualizado em novembro 26, 2025
Manutenção pharmaceutical cold chain storage is no longer a niche concern—it’s a critical safeguard for patients and supply chains. Por 2025 the global cold chain logistics market is forecast to surge from NÓS $324.85 bilhão em 2024 to US $862.33 bilhão por 2032. Most vaccines and biologic medicines must be stored within 2–8 ° C., while advanced therapies may require –20 °C, –80 °C or even –150 °C. Failure to control temperature is costly—up to 20 % of temperature sensitive drugs are compromised during transit and nearly 50 % of vaccines worldwide are wasted due to poor cold chain management. This comprehensive guide explains why the cold chain matters, how to meet strict regulations, which technologies and packaging options to consider, and what trends will shape the future of pharmaceutical storage.
Understand why cold chain storage is critical for patient safety and financial integrity.
Learn temperature requirements para vacinas, Biologics, cell and gene therapies and other medicines.
Navigate regulatory frameworks such as GDP, GMP and DSCSA.
Explore emerging technologies like IoT sensors, Otimização de rotas de IA, blockchain and solar powered units.
Choose packaging and equipment suited to different temperature ranges.
Implementar melhores práticas for continuous monitoring, staff training and contingency planning.
Entender 2025 tendências driving market growth and innovations.
Why Is Pharmaceutical Cold Chain Storage Critical?
Patient safety and product integrity: The efficacy of temperature sensitive products depends on strict storage conditions. Traditional vaccines must be kept at 2 °C a 8 °C, whereas gene therapies may need –20 °C ou menos. Even brief temperature excursions can render a vaccine or biologic ineffective because lost potency cannot be restored. Estudos estimam que até 20 % of temperature sensitive pharmaceuticals are compromised during transit, costing billions and risking patient health. O global cold chain market for pharmaceuticals—valued around NÓS $6.4 bilhão em 2024—is projected to reach NÓS $6.6 bilhão em 2025 and US $9.6 bilhão por 2035, highlighting rapid growth and the need for resilient infrastructure.
Financial and reputational stakes: Vaccine spoilage and product recalls are expensive. Improper temperature management wastes nearly 50 % of vaccines globally. Cold chain failures cost the biopharma sector billions in lost inventory and regulatory penalties. Maintaining a dependable cold chain ensures product integrity, supports compliance and protects your organization’s reputation.
Temperature Requirements and Product Categories
Different medicines require distinct temperature ranges. Understanding these ranges helps you choose appropriate equipment, packaging and monitoring systems.
| Categoria de produto | Faixa de temperatura típica | Por que isso importa | Benefício para você |
| Vacinas padrão | 2–8 ° C. (36–46°F) | A maioria das vacinas (flu, hepatite, HPV) remain potent only within this refrigerated range. | Ensures immunity and avoids costly re vaccinations. |
| Biologics & peptídeos | 2–8 ° C.; some require –20 °C | Anticorpos monoclonais, insulina, GLP 1 agonists and recombinant proteins degrade quickly outside controlled refrigeration. | Maintains drug efficacy and reduces patient risks. |
| Gene & terapias celulares | –80 °C a –150 °C (ultra cold or cryogenic) | CAR T therapies and viral vectors require cryogenic storage; temperatures can reach –190 °C. | Preserves living cells and maximizes therapeutic success. |
| Controlled room temperature medicines | 15–25ºC (59–77 °F) | Many oral drugs and some biologics can be stored at CRT, but still need monitoring to avoid heat or freeze damage. | Avoids product degradation and reduces energy costs. |
| Obesity medications | 2–8 ° C. | GLP 1 receptor agonists (por exemplo, Wegovy, Mounjaro) require refrigeration to remain potent. | Supports growing patient demand and reduces waste. |
Dicas práticas para usuários
Confirm the manufacturer’s recommended range for each product; never assume one range fits all medicines.
Use purpose built medical refrigerators, not household units; dormitory style fridges may freeze vaccines even when set to 5 °C.
Avoid frequent door openings to minimise warm air entry and temperature fluctuations.
Label storage areas clearly (por exemplo, “2–8 °C medicines”) to reduce handling errors.
Document every temperature measurement—accurate records support audits and help identify patterns of deviations.
Exemplo do mundo real: Durante o lançamento da vacina COVID 19, clinics using calibrated freezers with IoT sensors maintained ultra cold temperatures for mRNA vaccines. Continuous alerts enabled staff to correct deviations quickly, reducing spoilage and ensuring uninterrupted immunization.
Which Regulations Govern Pharmaceutical Cold Chain Storage?
The pharmaceutical cold chain operates within a web of global and regional regulations. O descumprimento pode gerar multas, shipment quarantines or even license suspension.
Good Distribution and Manufacturing Practice (GDP/GMP)
GDP and GMP guidelines—issued by bodies like the EMA, FDA and WHO—set standards for controle de temperatura, rastreabilidade e treinamento. Key principles include:
Controle de temperatura: Keep medicines within specified ranges (geralmente 2–8 ° C.) unless otherwise indicated. Use calibrated thermometers and temperature mapping to validate storage conditions.
Qualified equipment: Uso validado, regularly calibrated refrigerators, freezers, cold rooms and data loggers. Packaging solutions should offer adequate insulation and thermal protection.
Monitoring and documentation: Implement continuous monitoring systems with real time alerts and maintain detailed records. Blockchain technology offers tamper proof end to end traceability.
Gestão de risco: Identify potential risks (power failures, atrasos no trânsito, equipment malfunctions) and develop contingency plans.
Treinamento de pessoal: Treine a equipe sobre o manuseio adequado, storage and emergency procedures.
Lei de Segurança da Cadeia de Abastecimento de Medicamentos (DSCSA)
Nos Estados Unidos, o DSCSA mandates a fully electronic, sistema de rastreamento interoperável até agosto 27 2025. Após esta data, wholesale distributors must exchange transaction information, verify product identifiers at the package level and report suspect medications. Non compliance can result in fines, quarentenas de remessa ou suspensão de licença. Dispensers must also electronically trace products and report suspect or illegitimate drugs, with phased deadlines extending to novembro 2026 para pequenos dispensadores.
Other Regional Frameworks
Boas Práticas de Distribuição da UE (PIB) Diretrizes: Anexo 11 of the EU’s GMP requires validated electronic systems and secure data handling.
United States Pharmacopeia (USP) <1079>: Offers guidelines for shipping temperature sensitive products.
IATA and WHO: Provide protocols for shipping with dry ice and handling vaccines.
Tabela Regulatória
| Regulamento | Scope and key requirements | Implicações |
| DSCSA (NÓS) | Electronic traceability, serialised product identifiers, full data exchange by August 27 2025 | Requires interoperable systems and strong data management; non compliance can halt shipments. |
| EU GDP/GMP | Validated electronic systems, secure data handling, audit trails | Mandates calibrated equipment, electronic records and user access controls. |
| USP <1079> | Guidelines for shipping temperature sensitive products | Supports best practices for packaging, monitoramento e documentação. |
| IATA/WHO | Standards for transporting vaccines and dry ice | Ensures safe air transport and global consistency. |
Dicas práticas para usuários
Review upcoming DSCSA deadlines and assess whether your systems meet interoperability requirements.
Map your global operations to identify which regional guidelines apply; adapt processes accordingly.
Create a compliance checklist covering calibration, monitoramento, documentação e treinamento.
Partner with vendors who provide validated equipment and can supply documentation for audits.
Exemplo do mundo real: A U.S. wholesale distributor modernized its warehouse management system to meet DSCSA requirements. By August 2025 it had integrated serialisation, digital documentation and secure user access, avoiding shipment delays and regulatory penalties.
What Technologies Are Transforming Cold Chain Storage in 2025?
A new generation of digital tools and hardware is enhancing visibility, control and efficiency across the cold chain.
IoT Enabled Sensors and Real Time Monitoring
IoT devices—such as smart tapes, sensors and GPS trackers—collect data on temperature, umidade e localização em tempo real. Quando os sensores detectam temperaturas inseguras, they automatically send alerts via text or email, permitindo ação corretiva rápida. IoT sensors with GPS also enable end to end visibility for stakeholders. Predictive analytics can reduce unplanned equipment downtime by até 50 % e reduzir os custos de reparação 10–20 %.
Inteligência artificial (IA) and Predictive Analytics
AI algorithms analyse historical and real time data to optimise shipping routes, prever a demanda e prever falhas de equipamentos. AI powered route optimisation considers traffic and weather conditions, reducing transit time and quality degradation. Predictive analytics can also identify upcoming temperature excursions and trigger alerts. Studies indicate that AI can improve decision making and reduce costs across the cold chain.
Blockchain for End to End Traceability
Blockchain creates a tamper proof ledger linking every transaction chronologically. For pharmaceutical supply chains, blockchain ensures data integrity, prevents manipulation e enhances compliance. Real time temperature logs, shipment times and custody data can be shared securely among stakeholders. This transparency builds trust and simplifies audits.
Solar Powered and Sustainable Cold Storage
Unreliable power grids in rural areas and rising energy costs have spurred unidades de armazenamento refrigerado movidas a energia solar. Solar installations reduce total energy costs; utility rates average 13.10 centavos por kWh while commercial solar can cost 3.2–15,5 centavos por kWh. Solar solutions support remote clinics and advance sustainability goals. Enquanto isso, embalagem sustentável—including recyclable insulated containers and biodegradable wraps—reduces environmental impact and meets consumer expectations.
Automação e Robótica
Instalações frigoríficas estão adotando sistemas automatizados de armazenamento e recuperação (AS/RS) and robotic handling to address labour shortages and increase efficiency. Robots minimise human error and operate without breaks, improving throughput. Automation also provides consistent temperature control and inventory accuracy. According to industry estimates, sobre 80 % dos armazéns permanecem não automatizados, highlighting room for growth.
Portable Cryogenic Freezers and Modular Ultra Cold Storage
Advanced therapies often require ultra cold temperatures as low as –80 °C a –150 °C. Portable cryogenic freezers maintain these temperatures even in challenging environments and provide real time tracking and warning notifications. Modular ultra cold units allow facilities to scale capacity quickly, while multi temperature zones accommodate 2–8 °C, –20 °C and –80 °C products.
Summary of Innovations
| Tecnologia | Principais benefícios | O que isso significa para você |
| IoT sensors and GPS | Real time temperature and location data, alertas automatizados | Prevents excursions, optimises routes and enhances visibility. |
| Otimização de rotas de IA | Forecasts demand, identifies optimal paths | Reduces transit time and preserves product quality. |
| Blockchain | Tamper proof records, secure data sharing | Simplifies audits and strengthens compliance. |
| Armazenamento movido a energia solar | Custos de energia mais baixos, remote operation | Enables sustainable cold chain in off grid areas. |
| Automation/Robotics | Continuous operation, fewer errors | Improves warehouse efficiency and labour utilisation. |
| Congeladores criogênicos portáteis | Ultra cold storage and mobility | Supports gene and cell therapies in diverse locations. |
Dicas práticas para usuários
Implementar sensores IoT on every shipment to monitor temperature and location.
Use AI enabled route planning to adjust deliveries based on real time traffic and weather.
Adopt blockchain based logs for high value or highly regulated products.
Evaluate solar options if your facility faces unreliable power or high energy costs.
Plan for automation to cope with labour shortages and ensure consistency.
Exemplo do mundo real: A Southeast Asian logistics provider deployed blockchain and IoT sensors to monitor vaccine shipments. By sharing real time temperature and humidity logs with all stakeholders, the system eliminated data manipulation and improved regulatory compliance.
How to Choose Packaging and Equipment for Cold Chain Storage
Effective cold chain management requires more than refrigerators. Packaging and equipment must preserve product integrity during manufacturing, storage and transport.
Opções de embalagem
Insulated containers and liners: Caixas isoladas, pallet shippers and reusable crate liners account for about 40 % of the cold chain packaging market. They maintain temperature stability during transport and storage and can be reused to reduce costs.
Pallet shippers: Holding roughly 25 % do mercado, they are designed for large-volume shipments and can keep products at specific temperatures for days.
Materiais de mudança de fase (PCMs): PCMs and gel packs provide precise temperature control by absorbing or releasing latent heat within defined ranges. Custom PCM packs are available for frozen (–20 °C), refrigerado (+5 °C) e ambiente (+22 °C) estabilidade.
Painéis de isolamento a vácuo (VIPs): VIPs offer superior insulation and thermal stability and can be custom shaped.
Cryovac vacuum-sealed packaging: Removes air and offers leak resistant protection while reducing plastic use.
Plataformas de embalagens inteligentes: Integrate AI and IoT to recommend appropriate packaging and track temperature in real time.
Reutilizável vs.. Single Use Packaging
Reusable systems reduce total cost of ownership and environmental impact; o mercado para reusable temperature controlled packaging reached US $2.5 bilhão em 2024 e espera-se que duplique 2033. Single use options may be necessary for regulatory reasons or when return logistics are impractical. Ao escolher a embalagem, consider route duration, seasonal temperatures and sustainability goals.
Equipment Considerations
Medical-grade refrigerators and freezers: Provide uniform temperature and microprocessor controls with alarms. Avoid dormitory-style units which can freeze vaccines.
Ultra low freezers: Required for biologics and gene therapies needing –80 °C to –150 °C storage. Units should have redundancy and backup power.
IoT-enabled shippers and data loggers: Provide continuous temperature and location data; calibrate regularly.
Backup generators and redundant power: Ensure temperature stability during outages.
Packaging Selection Table
| Solução | Temperature range supported | Casos de uso | Vantagens |
| Recipientes isolados (PPE, VIP) | 2–8 ° C.; –20 °C; –80 °C (with appropriate refrigerants) | Remessas de vacinas, Biologics, insulina | Leve, reutilizável, tamanhos personalizados; maintain temperature for 96 h or more. |
| Pallet shippers | 2–8 ° C.; –20 °C; cryogenic with dry ice | Large-volume distribution, international transport | Long hold times, durável; can integrate smart sensors. |
| PCM and gel packs | Specific ranges (–20 °C, +5 °C, +22 °C) | Remessas mistas, ensaios clínicos | Controle preciso de temperatura, reutilizável; safe for dry ice restrictions. |
| Cryogenic freezers and LN2 vapour shippers | –80 °C to –190 °C | Cell and gene therapy, tissue engineering | Maintain viability of living cells; require specialized handling. |
| Embalagem inteligente | All ranges; dynamic | High value biologics, entregas remotas | Data integration, route optimisation; reduces packaging errors. |
Dicas práticas para usuários
Conduct thermal validation of packaging for specific routes and conditions.
Pre-condition refrigerants (pacotes de gel, PCM) to the correct temperature before packing.
Avoid mid-route repacking; each opening introduces risk.
Use data loggers and GPS trackers to document temperature throughout transit.
Considere sistemas reutilizáveis for regular routes to reduce costs and waste.
Exemplo do mundo real: A biotech firm shipping a gene therapy used cryogenic LN2 vapour shippers with IoT sensors. These containers maintained –150 °C conditions for over 120 hours and provided real time data, enabling proactive interventions and avoiding product loss.
Best Practices for Implementing a Compliant Cold Chain System
A robust cold chain extends beyond equipment. It relies on processes, people and risk management.
Core Components Across the Cold Chain
| Estágio | Key activities | Faixa de temperatura típica | Implicações práticas |
| Manufacturing | Maintain specified temperatures for raw materials and finished products. Determine optimal storage ranges for each step and document them for tech transfer. | 2–8 ° C. for most biologics; –20 °C ou menos for gene therapies. | Ensures ingredients remain stable; prevents product degradation before packaging. |
| Armazenar | Use refrigerators, cold rooms and warehouses with continuous monitoring and alarms to alert deviations. | 2–8 ° C. (refrigerado) or lower for ultra cold products. | Protects inventory; temperature logs support audits and recalls. |
| Transporte | Employ refrigerated vehicles and insulated packaging; data loggers track conditions in transit. | Geralmente 2–8 ° C.; dry ice or liquid nitrogen for cryogenic transport. | Minimises risk during delivery; documents chain of custody. |
| Distribuição | Wholesalers and pharmacies use controlled facilities until dispensing. | Same as storage. | Ensures final product quality and prevents waste. |
Best Practice Checklist
Validar equipamento: Confirm that refrigerators, freezers and data loggers meet GMP/GDP standards and calibrate them regularly.
Implementar monitoramento contínuo: Use IoT devices and alarm systems to track temperature and humidity in real time.
Maintain robust documentation: Registrar dados de temperatura, calibration certificates and handling procedures; consider blockchain for tamper proof records.
Treinar pessoal: Provide comprehensive training on GDP requirements, equipment operation and emergency response. Encourage staff to report issues promptly.
Desenvolver planos de contingência: Prepare backup power sources, alternative routes and protocols for transferring products to secondary storage.
Conduct risk assessments: Identify potential failures (quedas de energia, vehicle breakdowns, extreme weather) and mitigate them with redundancy and predictive tools.
Audit regularly: Periodic audits verify compliance and uncover gaps. Include external partners in your audit schedule.
Ferramenta de autoavaliação (Interactive Idea)
Para envolver os leitores, consider adding a simple Questionário de preparação para a cadeia de frio on your website. Ask questions like:
Do you know the correct storage temperature for each of your products?
Are your refrigerators and freezers calibrated and validated within the last year?
Do you use real time monitoring with alerts?
Do you have documented SOPs for packing and handling?
Is there a contingency plan for power failures or transit delays?
A score at the end can direct users to resources or services to address their gaps.
Exemplo prático: A regional pharmacy chain implemented a quarterly self assessment based on GDP guidelines. Scores highlighted weak areas in staff training and documentation, leading to targeted improvements and a 30 % reduction in temperature excursions over six months.
2025 Trends and Market Outlook for Pharmaceutical Cold Chain Storage
Visão geral de tendências
The pharmaceutical cold chain is expanding rapidly due to new therapies, rising consumer expectations and sustainability mandates. As principais tendências incluem:
Automação e robótica: Cold storage facilities increasingly deploy robotics to compensate for labour shortages and improve consistency.
Sustentabilidade: Refrigeração com eficiência energética, renewable energy and recyclable packaging are becoming industry standards.
Visibilidade de ponta a ponta: Wider adoption of advanced tracking systems provides real time location and temperature data.
Infrastructure modernisation: Upgrades in insulation, refrigeration systems and on site renewable power are essential to meet efficiency and compliance demands.
IA e análise preditiva: IA otimiza rotas, forecasts demand and predicts equipment failures.
Growth in the pharmaceutical sector: Demand for temperature sensitive drugs and biologics drives expansion.
Parcerias estratégicas e integração: Collaboration across manufacturers, packaging suppliers and logistics providers improves resilience.
Últimos destaques do progresso
Rise of biologics and advanced therapies: Sobre 40 % de medicamentos recentemente aprovados em 2024 eram biológicos, many requiring cold or ultra cold storage. The cell and gene therapy market is expected to reach NÓS $74.03 bilhão por 2034, necessitating cryogenic logistics.
Refrigerated storage growth: Demand for 2–8 °C storage is forecasted to grow faster than other temperature segments; Biologics (6 % Cagr) e vacinas (5 % Cagr) are driving this surge. Obesity medications are expected to triple in volume by 2030.
Cold storage market expansion: The global cold storage market (covering food and pharmaceuticals) está projetado para crescer a partir NÓS $35.7 bilhão em 2025 to US $72 bilhão por 2033. Key drivers include advanced temperature monitoring, energy efficient designs and rising pharmaceutical distribution needs.
Modernisation of warehouses: Aproximadamente 80 % dos armazéns permanecem não automatizados, providing significant potential for robotics and automation.
High market growth for cold chain logistics: The global cold chain logistics market is predicted to grow from NÓS $324.85 bilhão em 2024 to US $862.33 bilhão por 2032 due to demand for biologics and stricter regulations.
Insights de mercado
As therapies become more sophisticated, temperature controlled logistics is now a strategic asset. Biologics and personalized medicines are highly sensitive to temperature variations and frequently require refrigerated storage. Vaccines—both seasonal and emergent—continue to rely on cold chains, with most finished products needing 2–8 °C storage. Rare disease treatments and specialty drugs often fall within the same range. The global rise in obesity and the popularity of GLP 1 receptor agonists are fueling explosive growth in refrigerated drug volumes.
Environmental and ESG pressures are pushing companies to adopt energy efficient refrigeration technologies, renewable energy sources and embalagem biodegradável. Governments and investors are scrutinizing carbon footprints, tornando a sustentabilidade uma necessidade competitiva. Strategic partnerships and data standardization are enabling better integration across supply chains—by 2025, 74 % espera-se que os dados logísticos sejam padronizados, improving visibility and resilience.
Perguntas frequentes
Q1: What does pharmaceutical cold chain storage mean?
Cold chain storage refers to the system of controlling temperature during the manufacturing, armazenar, transportation and distribution of temperature sensitive medicines. It ensures products like vaccines, biologics and gene therapies stay within specific ranges (por exemplo, 2–8 °C ou –20 °C) to maintain potency and safety.
Q2: How are temperature ranges categorized in the cold chain?
The Healthcare Distribution Alliance classifies four ranges: refrigerado (2–8 ° C.) for insulin and many vaccines; congelado (–20 to –40 °C) for DNA and mRNA vaccines; ultralow (–45 to –93 °C) for certain vaccines; e criogênico (–150 to –190 °C) para terapias celulares e genéticas. Knowing these categories helps select suitable equipment and packaging.
Q3: What happens if temperature excursions occur?
Temperature excursions—when products fall outside recommended ranges—are the leading cause of product loss. Até 80 % of pharmaceutical losses are attributed to temperature excursions. Excursions can degrade drug potency, trigger costly recalls and compromise patient safety. Implement continuous monitoring and contingency plans to mitigate risks.
Q4: How can pharmacies ensure compliance with GDP guidelines?
Pharmacies should implement validated equipment, continuous monitoring with real time alerts, robust documentation and regular staff training. They must maintain products within 2–8 °C or other specified ranges, conduct risk assessments and develop contingency plans for power outages or transit delays.
Q5: What new technologies are emerging in 2025 for cold chain storage?
Key innovations include IoT enabled sensors for real time monitoring, Otimização de rotas orientada por IA, blockchain for tamper proof recordkeeping, solar powered cold storage and automation/robotics to streamline cold storage operations.
Q6: Why is sustainability important in pharmaceutical cold chains?
Cold storage facilities account for a significant portion of energy consumption and carbon emissions. Sustainable practices—such as using renewable energy, energy efficient refrigeration systems and recyclable packaging—reduce environmental impact and help companies meet regulatory and consumer expectations. Solar powered units can also lower operational costs.
Q7: How will the cold chain evolve over the next decade?
The next ten years will see rapid growth in 2–8 °C storage, automation and real time visibility. Biologics are projected to grow 6 % Cagr através 2035, vacinas 5 %, and obesity medications will triple by 2030. Ultra cold logistics will expand to support cell and gene therapies, while sustainable and modular solutions will become standard.
Resumo e recomendações
Reliable pharmaceutical cold chain storage protects patient safety, supports regulatory compliance and prevents costly product losses. As principais conclusões incluem:
Maintain strict temperature control: Know the correct range for each product and use validated equipment and calibrated sensors.
Cumpra os regulamentos: Follow GDP/GMP guidelines and prepare for DSCSA traceability requirements by August 27 2025.
Aproveite a tecnologia: Adote sensores IoT, Otimização de rotas de IA, blockchain logs and energy efficient solutions to enhance visibility and reduce risk.
Escolha a embalagem certa: Select insulated containers, PCMs or cryogenic solutions based on temperature requirements and route duration.
Invest in training and contingency planning: Educate staff on handling protocols and prepare for emergencies.
PRÓXIMOS PASSOS (Chamado à ação)
Avalie a preparação da sua cadeia de frio: Use a self assessment quiz to identify gaps in equipment, monitoramento, documentação e treinamento.
Upgrade your monitoring infrastructure: Implement IoT and AI tools to gain real time visibility and predictive insights.
Envolva-se com especialistas: Consult supply chain specialists to validate packaging and logistics strategies.
Planeje a conformidade: Create a DSCSA compliance roadmap covering electronic traceability, serialisation and user access controls.
Priorize a sustentabilidade: Explore solar powered storage, recyclable packaging and energy efficient refrigeration to reduce costs and environmental impact.
Sobre Tempk
Tempk is a leading provider of cold chain packaging and temperature control solutions. Projetamos e fabricamos caixas isoladas, Tampas de paletes, gel packs and reusable packaging tailored for pharmaceutical shipments. Nosso multi temperature product lines support 0–10 °C, 10 °C e abaixo, and ultra cold ranges to meet diverse logistics needs. With an in house R&D centre and stringent quality control, we deliver validated systems that help customers comply with GDP/GMP requirements and reduce waste. Nosso eco friendly product portfolio emphasises reusability and recyclable materials, apoiando metas de sustentabilidade.
What We Offer
Customised cold chain packaging: From gel packs and insulated bags to vacuum insulated panels and electric cooler bags, we offer solutions for every temperature range and shipment duration.
Regulatory support: Our products come with validation data and compliance documentation to simplify audits.
Inovação: We invest in advanced materials and digital monitoring to help clients stay ahead of evolving regulations and technologies.
Pronto para fortalecer sua cadeia de frio? Contact Tempk for tailored packaging solutions and expert guidance on building a resilient, sustainable cold chain system.
